Allergy and Immunology Billing Services in Edison, New Jersey

In a market like Edison, the fastest-growing and highest-risk part of an allergy practice's revenue is the buy-and-bill biologic program for severe asthma and chronic urticaria. These drugs can cost tens of thousands of dollars per patient each year, which means a single mishandled claim erases the margin on dozens of office visits. Three things decide whether that drug pays: exact HCPCS unit math, the JW or JZ discarded-drug modifier applied correctly on single-dose vials, and prior authorization confirmed before the drug is ever administered. Skip verification of benefits and you risk buying a drug the plan routes to the pharmacy benefit instead of the medical benefit — and eating the cost.

We build the buy-and-bill workflow around that reality. Before administration, we run verification of benefits and confirm the prior authorization, we determine whether the drug falls under the medical or pharmacy benefit for that specific plan, and we document the exact vial size so the discarded-drug modifier is defensible. New Jersey's dense commercial market makes this especially important: with so many employer plans in play across Middlesex County, no two payers handle biologic authorization identically, and an outsourcing allergy and immunology billing services partner has to track each one. This is exactly the kind of high-dollar, high-audit work that a general biller is not staffed to manage at allergy volume.

The stakes compound when a practice runs both a shot clinic and a biologic program under one roof, which is common in a referral hub like Edison. The shot clinic generates a high volume of lower-dollar claims where testing-unit accuracy and clean administration coding decide the margin; the biologic program generates a small number of very high-dollar claims where a single authorization gap or unit error is a catastrophic write-off. Blending the two into one generic billing process guarantees one of them is mishandled. We keep the workflows separate, so the specialist watching a $30,000-a-year drug claim is focused on authorization and discarded-drug math, while the team scaling your testing volume is focused on caps and administration lines. That separation is where an Edison practice recovers revenue it did not know it was losing, and it is the single biggest reason to move billing to a specialist.

Practices choose to outsource allergy and immunology billing in Edison because the revenue lives in unit counting and buy-and-bill drug capture that a general biller routinely misses. Outsourcing allergy and immunology billing services to a dedicated allergy and immunology billing company means the mixing log, the testing caps, the prior-auth queue, and the discarded-drug math are handled by specialists who do only this work. As a medical billing services company built for specialty revenue, we bring AAPC- and AHIMA-certified coders, a dedicated account manager who knows the New Jersey payer mix, and a free 360-degree reporting dashboard that shows every claim, denial, and A/R dollar in real time.

Our performance standards are the ones an allergy practice actually feels: a 99% first-pass clean-claim rate, roughly 99% net collections, days in A/R held under 25, up to 40% fewer denials, and up to 90% recovery on denied claims, with claims submitted within 24 hours. We have run specialty revenue cycles since 2005 — more than 20 years — with a 98% client retention rate, operating under HIPAA and SOC 2 Type II controls as an HBMA member. Handing billing to an outside partner should never cost you visibility, so you keep a direct line to your account manager and a live view of the pipeline. You can review our allergy and immunology billing overview or see the wider state picture on our allergy and immunology billing in New Jersey page. We also handle eligibility verification and prior authorization services as part of the engagement.

An Edison allergist is paid for units and drugs, not for the office visit. Percutaneous and intradermal testing is reported per individual test, never as one panel, and each test must fall inside the payer's annual cap and medically-unlikely-edit ceiling — miss that and a fifteen-test panel pays as one. Antigen preparation is priced from the mixing log at one billable dose per cc, with ten doses per Medicare multidose vial, and the antigen line is separate from the administration line. Venom immunotherapy is coded by venom count. Modifier 25 belongs only on a distinct, documented same-day evaluation, never on a routine shot day, and large non-covered food-sensitivity panels have to be screened to patient responsibility before they are performed.

Edison's payer landscape rewards that precision. New Jersey's employer density gives the township a heavy commercial share, so each plan's testing cap and preauthorization list must be tracked on its own. NJ FamilyCare, the state's Medicaid and CHIP program, runs through managed-care organizations — Horizon NJ Health, Aetna Better Health of New Jersey, UnitedHealthcare Community Plan, WellCare, and Fidelis Care — each carrying its own testing-unit limits, prior-auth rules, and vaccine routing for pediatric practices serving Edison's diverse, family-heavy neighborhoods. Medicare Part B claims route through Novitas Solutions as the Jurisdiction L contractor, which publishes the local coverage rules governing immunotherapy and skin-test units in New Jersey. A billing services company that cannot tell a commercial cap from a FamilyCare one will underpay the skin-test lines every week.